Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Khaled Essawi"'
Autor:
Khaled Essawi, Waleed Hakami, Muhammad Behroz Naeem Khan, Reid Martin, Jing Zeng, Rebecca Chu, Naoya Uchida, Aylin C. Bonifacino, Allen E. Krouse, Nathaniel S. Linde, Robert E. Donahue, Gerd A. Blobel, Ulrike Gerdemann, Leslie S. Kean, Stacy A. Maitland, Scot A. Wolfe, Jean-Yves Metais, Stephen Gottschalk, Daniel E. Bauer, John F. Tisdale, Selami Demirci
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 29, Iss , Pp 483-493 (2023)
CRISPR-Cas9-based therapeutic genome editing approaches hold promise to cure a variety of human diseases. Recent findings demonstrate pre-existing immunity for the commonly used Cas orthologs from Streptococcus pyogenes (SpCas9) and Staphylococcus au
Externí odkaz:
https://doaj.org/article/186bb2a612c54f99a14f07e9473590ec
Autor:
Scott A. Peslak, Selami Demirci, Vemika Chandra, Byoung Ryu, Saurabh K. Bhardwaj, Jing Jiang, Jeremy W. Rupon, Robert E. Throm, Naoya Uchida, Alexis Leonard, Khaled Essawi, Aylin C. Bonifacino, Allen E. Krouse, Nathaniel S. Linde, Robert E. Donahue, Francesca Ferrara, Matthew Wielgosz, Osheiza Abdulmalik, Nicole Hamagami, Paula Germino-Watnick, Anh Le, Rebecca Chu, Malikiya Hinds, Mitchell J. Weiss, Wei Tong, John F. Tisdale, Gerd A. Blobel
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 31, Iss , Pp 452-465 (2023)
Transcriptional enhancers can be in physical proximity of their target genes via chromatin looping. The enhancer at the β-globin locus (locus control region [LCR]) contacts the fetal-type (HBG) and adult-type (HBB) β-globin genes during correspondi
Externí odkaz:
https://doaj.org/article/32788d42c8a3431085e1147f913baa4b
Autor:
Waleed Hakami, Gasim Dobie, Abdullah A Mobarki, Aymen M Madkhali, Mohmmad S. Akhter, Abdulrahim R Hakami, Mohammed H Nahari, Yahya H Matari, Khaled Essawi, Ali Hakamy, Mohammad Algahtani, Denise E Jackson, Hassan A Hamali
Publikováno v:
European Journal of Inflammation, Vol 21 (2023)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is still a global concern with high morbidity and mortality rates. The role of endothelial cells in the progress of COVID-19 is well established. Therefore, the current study aimed to measu
Externí odkaz:
https://doaj.org/article/cee8897484b94aefb66f9f0b116fa9e5
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 23, Iss , Pp 276-285 (2021)
Genome editing is potentially a curative technique available to all individuals with β-hemoglobinopathies, including sickle cell disease (SCD). Fetal hemoglobin (HbF) inhibits sickle hemoglobin (HbS) polymerization, and it is well described that nat
Externí odkaz:
https://doaj.org/article/0228fe37fd1a4d9d890c97a21cc6c425
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Selami Demirci, Juan J. Haro-Mora, Alexis Leonard, Claire Drysdale, Daniela Malide, Keyvan Keyvanfar, Khaled Essawi, Raul Vizcardo, Naritaka Tamaoki, Nicholas P. Restifo, John F. Tisdale, Naoya Uchida
Publikováno v:
Stem Cell Research & Therapy, Vol 11, Iss 1, Pp 1-1 (2020)
An amendment to this paper has been published and can be accessed via the original article.
Externí odkaz:
https://doaj.org/article/07b8e6884a6c45098aefde61ecdd133f
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 23, Iss, Pp 276-285 (2021)
Molecular Therapy. Methods & Clinical Development
Molecular Therapy. Methods & Clinical Development
Genome editing is potentially a curative technique available to all individuals with β-hemoglobinopathies, including sickle cell disease (SCD). Fetal hemoglobin (HbF) inhibits sickle hemoglobin (HbS) polymerization, and it is well described that nat
Autor:
Selami Demirci, Khaled Essawi, Paula Germino-Watnick, Xiong Liu, Waleed Hakami, John F. Tisdale
Publikováno v:
CRISPR J
With the advent of new genome editing technologies and the emphasis placed on their optimization, the genetic and phenotypic correction of a plethora of diseases sit on the horizon. Ideally, genome editing approaches would provide long-term solutions
Autor:
Gasim Dobie -; Department of Medical Laboratory Technology, Jazan University, Gizan, Saudi Arabia., Hassan A Hamali -; Department of Medical Laboratory Technology, Jazan University, Gizan, Saudi Arabia., Abdullah A Mobarki -; Department of Medical Laboratory Technology, Jazan University, Gizan, Saudi Arabia., Muhammad Saboor -; Department of Medical Laboratory Sciences, College of Health Sciences, University of Sharjah, Sharjah, UAE., Mohammad S Akhter -; Department of Medical Laboratory Technology, Jazan University, Gizan, Saudi Arabia., Khaled Essawi Abdulrahim R Hakami -; Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Khalid University, Abha Saudi Arabia., Mohammed H Nahari -; Department of Medical Laboratory Technology, Najran University, Najran, Saudi Arabia., Mohamed A Kolaiby -; Department of Hematology and Blood Bank, Sabya General Hospital, Gizan, Saudi Arabia., Yahya H Matari -; Department of Hematology and Blood Bank, Baish General Hospital, Gizan, Saudi Arabia., Essa Atafi -; Department of Hematology and Blood Bank, Baish General Hospital, Gizan, Saudi Arabia., Ghalib Ghubiri -; Department of Hematology and Blood Bank, Baish General Hospital, Gizan, Saudi Arabia., Abdulrahman A Alhamzi -; Department of Hematology and Blood Bank, King Fahd Central Hospital, Gizan, Saudi Arabia., Abdulrhman Alhamzi -; Department of Planning and Development, King Fahd Central Hospital, Gizan, Saudi Arabia., Amr J Halawani -; Deaprtment of Laboratory Medicine, Faculty of Applied Medical Sciences, Umm Al-Qura University, Makkah, Saudi Arabia., Abdullah Hamadi -; Department of Medical Laboratory Technology, Tabuk University, Tabuk, Saudi Arabia., Denise E Jackson -; Thrombosis and Vascular Diseases Laboratory, School of Health and Biomedical Sciences, Royal Melbourne Institute of Technology (RMIT) University, Bundoora, VIC, Austra.
Publikováno v:
Pakistan journal of pharmaceutical sciences [Pak J Pharm Sci] 2023 Jul; Vol. 36 (4), pp. 1211-1215.
Autor:
Alexis Leonard, Nicholas P. Restifo, Juan J. Haro-Mora, Naritaka Tamaoki, Khaled Essawi, Naoya Uchida, Selami Demirci, Claire M. Drysdale, Keyvan Keyvanfar, Raul Vizcardo, Daniela Malide, John F. Tisdale
Publikováno v:
Stem Cell Research & Therapy
Background Ex vivo production of hematopoietic stem/precursor cells (HSPCs) represents a promising versatile approach for blood disorders. Methods To derive definitive HSPCs from human embryonic stem cells (ESCs), we differentiated mesodermally speci